Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy
Authors:
- 1 July 2012
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 130 (1) , 215-224.e7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Subcutaneous immunotherapyJournal of Allergy and Clinical Immunology, 2011
- Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut AllergyInternational Archives of Allergy and Immunology, 2010
- Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009Allergy, 2009
- Epigenetic mechanisms of regulation of Foxp3 expressionBlood, 2009
- Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case–control study on 171 patients. The EFESO‐children Multicenter TrialPediatric Allergy and Immunology, 2009
- Long-Lasting Effects of Sublingual Immunotherapy for House Dust Mites in Allergic Rhinitis with Bronchial Hyperreactivity: A Long-Term (13-Year) Retrospective Study in Real LifeInternational Archives of Allergy and Immunology, 2006
- Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsAnnals of Allergy, Asthma & Immunology, 2006
- The Basophil-Specific Ectoenzyme E-NPP3 (CD203c) as a Marker for Cell Activation and Allergy DiagnosisInternational Archives of Allergy and Immunology, 2004
- Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individualsAnnals of Allergy, Asthma & Immunology, 2004
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003